Healthcare provider profile · identity verified

Raquel Bolado, D.O.

Family Practice · HARLINGEN, TX · NPI 1679567713

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Losartan Potassium	Losartan Potassium	252	72
Atorvastatin Calcium	Atorvastatin Calcium	244	77
Metformin Hcl	Metformin Hcl	192	58
Pravastatin Sodium	Pravastatin Sodium	168	56
Amlodipine Besylate	Amlodipine Besylate	161	48
Lisinopril	Lisinopril	161	53
Levothyroxine Sodium	Levothyroxine Sodium	147	45
Gabapentin	Gabapentin	127	44
Hydrochlorothiazide	Hydrochlorothiazide	117	38
Fluticasone Propionate	Fluticasone Propionate	109	43
Albuterol Sulfate Hfa	Albuterol Sulfate	107	50
Montelukast Sodium	Montelukast Sodium	103	36
Rosuvastatin Calcium	Rosuvastatin Calcium	101	36
Omeprazole	Omeprazole	91	34
Metoprolol Succinate	Metoprolol Succinate	81	30
Tamsulosin Hcl	Tamsulosin Hcl	80	27
Alendronate Sodium	Alendronate Sodium	67	22
Metoprolol Tartrate	Metoprolol Tartrate	63	18
Glimepiride	Glimepiride	59	18
Pantoprazole Sodium	Pantoprazole Sodium	54	18
Methocarbamol	Methocarbamol	52	32
Hydroxyzine Hcl	Hydroxyzine Hcl	47	19
Ezetimibe	Ezetimibe	45	suppressed
Azithromycin	Azithromycin	43	41
Amitriptyline Hcl	Amitriptyline Hcl	39	suppressed
Famotidine	Famotidine	39	15
Baclofen	Baclofen	38	14
Prednisone	Prednisone	36	26
Sertraline Hcl	Sertraline Hcl	35	12
Simvastatin	Simvastatin	35	12
Diclofenac Sodium	Diclofenac Sodium	33	12
Duloxetine Hcl	Duloxetine Hcl	32	suppressed
Ibuprofen	Ibuprofen	32	12
Methylprednisolone	Methylprednisolone	32	27
Fluconazole	Fluconazole	31	23
Glipizide Er	Glipizide	31	11
Furosemide	Furosemide	30	12
Levofloxacin	Levofloxacin	30	27
Carvedilol	Carvedilol	29	suppressed
Meclizine Hcl	Meclizine Hcl	29	17
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	29	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	27	11
Allopurinol	Allopurinol	26	suppressed
Celecoxib	Celecoxib	25	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	25	suppressed
Topiramate	Topiramate	25	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	24	suppressed
Meloxicam	Meloxicam	24	14
Potassium Chloride	Potassium Chloride	24	suppressed
Clopidogrel	Clopidogrel Bisulfate	23	suppressed
Trazodone Hcl	Trazodone Hcl	23	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	23	16
Januvia	Sitagliptin Phosphate	22	suppressed
Warfarin Sodium	Warfarin Sodium	22	suppressed
Jardiance	Empagliflozin	21	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	21	suppressed
Buspirone Hcl	Buspirone Hcl	20	suppressed
Citalopram Hbr	Citalopram Hydrobromide	20	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	20	suppressed
Cephalexin	Cephalexin	19	19
Ondansetron Hcl	Ondansetron Hcl	19	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	18	13
Ciprofloxacin Hcl	Ciprofloxacin Hcl	17	16
Sucralfate	Sucralfate	17	suppressed
Constulose	Lactulose	16	suppressed
Humulin N	Insulin Nph Human Isophane	16	suppressed
Mupirocin	Mupirocin	16	15
Finasteride	Finasteride	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Gemfibrozil	Gemfibrozil	14	suppressed
Glipizide	Glipizide	14	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	14	suppressed
Enulose	Lactulose	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	11
Chlorhexidine Gluconate	Chlorhexidine Gluconate	12	12
Humulin R	Insulin Regular, Human	12	suppressed
Lactulose	Lactulose	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Metformin Hcl Er	Metformin Hcl	12	suppressed
Ozempic	Semaglutide	12	suppressed
Naproxen	Naproxen	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error